Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets(Parenthetical)

v3.22.1
Condensed Consolidated Balance Sheets(Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Accounts receivables and contract assets, allowance for credit losses $ 29 $ 28
Long-term Debt, Fair Value $ 272 $ 268
Series A    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 72,487,203 72,447,462
Common stock, shares outstanding 72,487,203 72,447,462
Series B    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 7,500,000 7,500,000
Common stock shares issued 3,370,368 3,216,047
Common stock, shares outstanding 3,370,368 3,216,047
Series C    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 0 0